中华创伤杂志
中華創傷雜誌
중화창상잡지
Chinese Journal of Traumatology
2015年
1期
50-53
,共4页
赵磊%吴春生%张英泽%李志杰%宋朝晖%宋连新%彭阿钦
趙磊%吳春生%張英澤%李誌傑%宋朝暉%宋連新%彭阿欽
조뢰%오춘생%장영택%리지걸%송조휘%송련신%팽아흠
静脉血栓形成%骨折,下肢%肝素,低分子量%疏血通
靜脈血栓形成%骨摺,下肢%肝素,低分子量%疏血通
정맥혈전형성%골절,하지%간소,저분자량%소혈통
Venous thrombosis%Fractures,lower extremity%Heparin,low-molecular-weight%Shuxuetong injection
目的 比较低分子量肝素与低分子量肝素联合疏血通对下肢骨折后深静脉血栓(DVT)的治疗效果. 方法 选择2010年12月-2012年11月下肢骨折患者1 037例,出现DVT患者79例,DVT发生率7.6%,纳入研究42例,男31例,女11例;平均年龄63岁(26~ 82岁).按随机数字表法分为低分子肝素组(A组,19例)和联合组(B组,23例)治疗.A组使用低分子肝素钠4 250 IU皮下注射,2次/d;B组使用低分子肝素钠4 250 IU皮下注射,2次/d,同时联合疏血通6 ml加入9g/L氯化钠注射液250 ml中静脉滴注,1次/d.每周为1个疗程,复查双下肢深静脉彩超. 结果 42例患者最长治疗时间为3周.A组中再通2例,平均时间2.50周;显效3例,平均时间2.67周;有效7例,平均时间3周;无明显变化或加重7例,平均时间3周.B组中再通7例,平均时间1.86周;显效12例,平均时间1.83周;有效3例,平均时间3周;无明显变化或加重1例,平均时间3周.两组差异有统计学意义(P<0.05). 结论 低分子量肝素联合疏血通治疗下肢骨折后DVT疗效明确,可以作为临床治疗骨折后DVT的选择之一.
目的 比較低分子量肝素與低分子量肝素聯閤疏血通對下肢骨摺後深靜脈血栓(DVT)的治療效果. 方法 選擇2010年12月-2012年11月下肢骨摺患者1 037例,齣現DVT患者79例,DVT髮生率7.6%,納入研究42例,男31例,女11例;平均年齡63歲(26~ 82歲).按隨機數字錶法分為低分子肝素組(A組,19例)和聯閤組(B組,23例)治療.A組使用低分子肝素鈉4 250 IU皮下註射,2次/d;B組使用低分子肝素鈉4 250 IU皮下註射,2次/d,同時聯閤疏血通6 ml加入9g/L氯化鈉註射液250 ml中靜脈滴註,1次/d.每週為1箇療程,複查雙下肢深靜脈綵超. 結果 42例患者最長治療時間為3週.A組中再通2例,平均時間2.50週;顯效3例,平均時間2.67週;有效7例,平均時間3週;無明顯變化或加重7例,平均時間3週.B組中再通7例,平均時間1.86週;顯效12例,平均時間1.83週;有效3例,平均時間3週;無明顯變化或加重1例,平均時間3週.兩組差異有統計學意義(P<0.05). 結論 低分子量肝素聯閤疏血通治療下肢骨摺後DVT療效明確,可以作為臨床治療骨摺後DVT的選擇之一.
목적 비교저분자량간소여저분자량간소연합소혈통대하지골절후심정맥혈전(DVT)적치료효과. 방법 선택2010년12월-2012년11월하지골절환자1 037례,출현DVT환자79례,DVT발생솔7.6%,납입연구42례,남31례,녀11례;평균년령63세(26~ 82세).안수궤수자표법분위저분자간소조(A조,19례)화연합조(B조,23례)치료.A조사용저분자간소납4 250 IU피하주사,2차/d;B조사용저분자간소납4 250 IU피하주사,2차/d,동시연합소혈통6 ml가입9g/L록화납주사액250 ml중정맥적주,1차/d.매주위1개료정,복사쌍하지심정맥채초. 결과 42례환자최장치료시간위3주.A조중재통2례,평균시간2.50주;현효3례,평균시간2.67주;유효7례,평균시간3주;무명현변화혹가중7례,평균시간3주.B조중재통7례,평균시간1.86주;현효12례,평균시간1.83주;유효3례,평균시간3주;무명현변화혹가중1례,평균시간3주.량조차이유통계학의의(P<0.05). 결론 저분자량간소연합소혈통치료하지골절후DVT료효명학,가이작위림상치료골절후DVT적선택지일.
Objective To compare the therapeutic results between low-molecular-weight heparin therapy and combined therapy of low-molecular-weight heparin and Shuxuetong for deep venous thrombosis (DVT) after lower extremity fracture.Methods Forty-two patients with DVT from 1,037 patients with lower extremity fracture treated from December 2010 through November 2012 were included in the study.There were 31 males and 11 females,aged from 26 to 82 years (mean,63 years).The patients were assigned to administration of 4,250 IU low-molecular-weight heparin subcutaneously,twice daily (Group A,n =19)and 4,250 IU low-molecular-weight heparin subcutaneously,twice daily plus shuxuetong to 6 ml intravenously,once daily (Group B,n =23) according to the random number table.A period of treatment was a week.Color Doppler sonography was performed to detect DVT.Results Longest course of treatment was 3 weeks.In Group A,the results were recanalization in 2 patients with mean time of 2.50 weeks,significantly effective in 3 patients with mean time of 2.67 weeks,effective in 7 patients with mean time of 3 weeks,and invalid or worse in 7 patients with mean time of 3 weeks.Whereas in Group B,the results were recanalization in 7 patients with mean time of 1.86 weeks,significantly effective in 12 patients with mean time of 1.83 weeks,effective in 3 patients with mean time of 3 weeks,and invalid or worse in 1 patient with mean time of 3 weeks (P < 0.05).Conclusion Low-molecular-weight heparin plus Shuxuetong is effective in treatment of DVT after lower extremity fracture and hence can be as an option in clinical application.